Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: TARGETED THERAPY, . Treffer: 132

2023

Alcaniz, J; Winkler, L; Dahlmann, M; Becker, M; Orthmann, A; Haybaeck, J; Krassnig, S; Skofler, C; Kratzsch, T; Kuhn, SA; Jödicke, A; Linnebacher, M; Fichtner, I; Walther, W; Hoffmann, J Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures.
Front Oncol. 2023; 13: 1129627 Doi: 10.3389/fonc.2023.1129627 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ascierto, PA; Mandalà, M; Ferrucci, PF; Guidoboni, M; Rutkowski, P; Ferraresi, V; Arance, A; Guida, M; Maiello, E; Gogas, H; Richtig, E; Fierro, MT; Lebbè, C; Helgadottir, H; Queirolo, P; Spagnolo, F; Tucci, M; Del, Vecchio, M; Gonzales, Cao, M; Minisini, AM; De, Placido, S; Sanmamed, MF; Mallardo, D; Curvietto, M; Melero, I; Palmieri, G; Grimaldi, AM; Giannarelli, D; Dummer, R; Chiarion, Sileni, V Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial.
J Clin Oncol. 2023; 41(2): 212-221. Doi: 10.1200/JCO.21.02961
Web of Science PubMed FullText FullText_MUG

 

Dai, Q; Zhang, J; Long, W; Haybaeck, J; Yang, Z Genetic alterations of GI-NECs involving three main signaling pathways.
Cancer Med. 2023; Doi: 10.1002/cam4.5633 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Suppan, C; Balic, M Current standards and future outlooks in metastatic Her2-positive breast cancer
BREAST CARE. 2023; Doi: 10.1159/000528756 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2022

Ailioaie, LM; Ailioaie, C; Litscher, G Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era.
Int J Mol Sci. 2022; 23(21): 12757 Doi: 10.3390/ijms232112757 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Bergler-Klein, J; Rainer, PP; Wallner, M; Zaruba, MM; Dörler, J; Böhmer, A; Buchacher, T; Frey, M; Adlbrecht, C; Bartsch, R; Gyöngyösi, M; Fürst, UM Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.
Wien Klin Wochenschr. 2022; 134(17-18):654-674 Doi: 10.1007/s00508-022-02031-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Dankner, M; Wang, Y; Fazelzad, R; Johnson, B; Nebhan, CA; Dagogo-Jack, I; Myall, NJ; Richtig, G; Bracht, JWP; Gerlinger, M; Shinozaki, E; Yoshino, T; Kotani, D; Fangusaro, JR; Gautschi, O; Mazieres, J; Sosman, JA; Kopetz, S; Subbiah, V; Davies, MA; Groover, AL; Sullivan, RJ; Flaherty, KT; Johnson, DB; Benedetti, A; Cescon, DW; Spreafico, A; Zogopoulos, G; Rose, AAN Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors.
JCO Precis Oncol. 2022; 6:e2200107 Doi: 10.1200/PO.22.00107
Web of Science PubMed FullText FullText_MUG

 

Gerger, A; Eisterer, W; Fuxius, S; Bastian, S; Koeberle, D; Welslau, M; Sanoyan, DA; Maas, C; Uhlig, J; Fenchel, K; Greil, R; VON, DER, Heyde, E; Agocs, GR; Weide, R; Schwager, M; Reichenbach, F; Modest, DP; Fritsch, R Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma - MORSECRC.
Anticancer Res. 2022; 42(10):4773-4785 Doi: 10.21873/anticanres.15982
Web of Science PubMed FullText FullText_MUG

 

Hochmair, MJ; Kolb, R; Wurm, R; Zach, H; Bittner, N Nintedanib plus Docetaxel after Immune Checkpoint Inhibitor Failure in Patients with Advanced Non-Small-Cell Lung Cancer: A Case Series
CASE REP ONCOL. 2022; 15(1): 138-148. Doi: 10.1159/000520939 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Huang, R; Dai, Q; Yang, R; Duan, Y; Zhao, Q; Haybaeck, J; Yang, Z A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma.
Front Oncol. 2022; 12: 817916 Doi: 10.3389/fonc.2022.817916 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Illini, O; Fabikan, H; Swalduz, A; Krenbek, D; Vikstrom, A; Schumacher, M; Dudnik, E; Studnicka, M; Ohman, R; Wurm, R; Wannesson, L; Peled, N; Kian, W; Bar, J; Daher, S; Addeo, A; Rotem, O; Pall, G; Zer, A; Saad, A; Cufer, T; Sorotsky, HG; Hashemi, SMS; Mohorcic, K; Stoff, R; Rovitsky, Y; Keren-Rosenberg, S; Winder, T; Weinlinger, C; Valipour, A; Hochmair, MJ Real-world Experience with Capmatinib in MET Exon 14-mutated Non-small Cell Lung Cancer (RECAP)
J THORAC ONCOL. 2022; 17(9): S460-S460. [Poster]
Web of Science

 

Illini, O; Fabikan, H; Swalduz, A; Vikstrom, A; Krenbek, D; Schumacher, M; Dudnik, E; Studnicka, M; Ohman, R; Wurm, R; Wannesson, L; Peled, N; Kian, W; Bar, J; Daher, S; Addeo, A; Rotem, O; Pall, G; Zer, A; Saad, A; Cufer, T; Sorotsky, HG; Hashemi, SMS; Mohorcic, K; Stoff, R; Rovitsky, Y; Keren-Rosenberg, S; Winder, T; Weinlinger, C; Valipour, A; Hochmair, MJ Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program
THER ADV MED ONCOL. 2022; 14: 17588359221103206 Doi: 10.1177/17588359221103206 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Jahn, A; Rump, A; Widmann, TJ; Heining, C; Horak, P; Hutter, B; Paramasivam, N; Uhrig, S; Gieldon, L; Drukewitz, S; Kubler, A; Bermudez, M; Hackmann, K; Porrmann, J; Wagner, J; Arlt, M; Franke, M; Fischer, J; Kowalzyk, Z; William, D; Weth, V; Oster, S; Frohlich, M; Hullein, J; Gonzalez, CV; Kreutzfeldt, S; Mock, A; Heilig, CE; Lipka, DB; Mohrmann, L; Hanf, D; Oles, M; Teleanu, V; Allgauer, M; Ruhnke, L; Kutz, O; Knurr, A; Lassmann, A; Endris, V; Neumann, O; Penzel, R; Beck, K; Richter, D; Winter, U; Wolf, S; Pfutze, K; Georg, C; Meissburger, B; Buchhalter, I; Augustin, M; Aulitzky, WE; Hohenberger, P; Kroiss, M; Schirmacher, P; Schlenk, RF; Keilholz, U; Klauschen, F; Folprecht, G; Bauer, S; Siveke, JT; Brandts, CH; Kindler, T; Boerries, M; Illert, AL; von Bubnoff, N; Jost, PJ; Metzeler, KH; Bitzer, M; Schulze-Osthoff, K; von Kalle, C; Brors, B; Stenzinger, A; Weichert, W; Hubschmann, D; Frohling, S; Glimm, H; Schrock, E; Klink, B Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
ANN ONCOL. 2022; 33(11): 1186-1199. Doi: 10.1016/j.annonc.2022.07.008
Web of Science PubMed FullText FullText_MUG

 

Klocker, EV; Balic, M; Steger, G Molecular profiling leading to personalized treatment in breast cancer
MEMO-MAG EUR MED ONC. 2022; Doi: 10.1007/s12254-021-00792-4
Web of Science FullText FullText_MUG

 

Meert, AP; Toffart, AC; Picard, M; Jaubert, P; Gibelin, A; Bauer, P; Mokart, D; Van, De, Louw, A; Hatzl, S; Moreno-Gonzales, G; Rousseau-Bussac, G; Bruneel, F; Montini, L; Moreau, AS; Carpentier, D; Seguin, A; Hemelaar, P; Azoulay, E; Lemiale, V When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study.
Bull Cancer. 2022; 109(9):916-924 Doi: 10.1016/j.bulcan.2022.04.014
Web of Science PubMed FullText FullText_MUG

 

Moik, F; Ay, C Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies
THROMB RES. 2022; 213: S58-S65. Doi: 10.1016/j.thromres.2022.01.004
Web of Science PubMed FullText FullText_MUG

 

Neumeister, P; Schulz, E; Pansy, K; Szmyra, M; Deutsch, AJ Targeting the Microenvironment for Treating Multiple Myeloma.
Int J Mol Sci. 2022; 23(14): 7627 Doi: 10.3390/ijms23147627 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Sallmon, H; Koestenberger, M; Avian, A; Reiterer, F; Schwaberger, B; Meinel, K; Cvirn, G; Kurath-Koller, S; Gamillscheg, A; Hansmann, G Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension.
J Perinatol. 2022; 42(6):781-787 Doi: 10.1038/s41372-022-01374-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schieffer, L; Manzl, C; Schatz, C; Haybaeck, J; Crismani, A Nrf2 in the Field of Dentistry with Special Attention to NLRP3.
Antioxidants (Basel). 2022; 11(1): Doi: 10.3390/antiox11010149 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Zacharias, M; Konjic, S; Absenger, G; Hochmair, MJ; Fabikan, H; Weinlinger, C; Illini, O; Jost, PJ; Schlintl, V; Wurm, R; Lindenmann, J; Fediuk, M; Brcic, L; Terbuch, A Clinicopathological Features of Rare but Targetable Mutations in Surgically Resected Lung Carcinomas
J THORAC ONCOL. 2022; 17(9): S201-S202. [Poster]
Web of Science

 

Zebisch, A; Sill, H How do non-coding RNAs impact treatment regimens currently being used in AML?
Expert Rev Anticancer Ther. 2022; 22(4):331-333 Doi: 10.1080/14737140.2022.2049764
Web of Science PubMed FullText FullText_MUG

 

2021

Brčić, I; Argyropoulos, A; Liegl-Atzwanger, B Update on Molecular Genetics of Gastrointestinal Stromal Tumors.
Diagnostics (Basel). 2021; 11(2): Doi: 10.3390/diagnostics11020194 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Brčić, I; Godschachner, TM; Bergovec, M; Igrec, J; Till, H; Lackner, H; Scheipl, S; Kashofer, K; Brodowicz, T; Leithner, A; Szkandera, J; Liegl-Atzwanger, B Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
Mod Pathol. 2021; 34(2):396-407 Doi: 10.1038/s41379-020-00657-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Farinazzo, E; Zelin, E; Agozzino, M; Papa, G; Pizzichetta, MA; di, Meo, N; Zalaudek, I Regression of nevi, vitiligo-like depigmentation and halo phenomenon may indicate response to immunotherapy and targeted therapy in melanoma.
Melanoma Res. 2021; 31(6): 582-585. Doi: 10.1097/CMR.0000000000000776
Web of Science PubMed FullText FullText_MUG

 

Frohlich, E; Wahl, R Nanoparticles: Promising Auxiliary Agents for Diagnosis and Therapy of Thyroid Cancers
CANCERS. 2021; 13(16): 4063 Doi: 10.3390/cancers13164063 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Illini, O; Hochmair, MJ; Fabikan, H; Weinlinger, C; Tufman, A; Swalduz, A; Lamberg, K; Hashemi, SMS; Huemer, F; Vikstrom, A; Wermke, M; Absenger, G; Addeo, A; Banerji, S; Calles, A; Clarke, S; Di Maio, M; Durand, A; Duruisseaux, M; Itchins, M; Kaaranien, OS; Krenn, F; Laack, E; de Langen, AJ; Mohorcic, K; Pall, G; Passaro, A; Prager, G; Rittmeyer, A; Rothenstein, J; Schumacher, M; Woll, E; Valipour, A Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program
THER ADV MED ONCOL. 2021; 13: 17588359211019675 Doi: 10.1177/17588359211019675 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kerr, DA; Thompson, LDR; Tafe, LJ; Jo, VY; Neyaz, A; Divakar, P; Paydarfar, JA; Pastel, DA; Shirai, K; John, I; Seethala, RR; Salgado, CM; Deshpande, V; Bridge, JA; Kashofer, K; Brčić, I; Linos, K Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck: Highlighting a Novel Fusion and Potential Diagnostic Pitfall.
Am J Surg Pathol. 2021; 45(12):1707-1719 Doi: 10.1097/PAS.0000000000001735
Web of Science PubMed FullText FullText_MUG

 

Lechner, M; Schartinger, VH; Steele, CD; Nei, WL; Ooft, ML; Schreiber, LM; Pipinikas, CP; Chung, GT; Chan, YY; Wu, F; To, KF; Tsang, CM; Pearce, W; Morelli, D; Philpott, M; Masterson, L; Nibhani, R; Wells, G; Bell, CG; Koller, J; Delecluse, S; Yip, YL; Liu, J; Forde, CT; Forster, MD; Jay, A; Dudás, J; Krapp, A; Wan, S; Uprimny, C; Sprung, S; Haybaeck, J; Fenton, TR; Chester, K; Thirlwell, C; Royle, G; Marafioti, T; Gupta, R; Indrasari, SR; Herdini, C; Slim, MAM; Indrawati, I; Sutton, L; Fles, R; Tan, B; Yeong, J; Jain, A; Han, S; Wang, H; Loke, KSH; He, W; Xu, R; Jin, H; Cheng, Z; Howard, D; Hwang, PH; Le, QT; Tay, JK; West, RB; Tsao, SW; Meyer, T; Riechelmann, H; Oppermann, U; Delecluse, HJ; Willems, SM; Chua, MLK; Busson, P; Lo, KW; Wollmann, G; Pillay, N; Vanhaesebroeck, B; Lund, VJ Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.
Nat Commun. 2021; 12(1): 117-117. Doi: 10.1038/s41467-020-20308-8 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Novoszel, P; Holcmann, M; Stulnig, G; De Sa Fernandes, C; Zyulina, V; Borek, I; Linder, M; Bogusch, A; Drobits, B; Bauer, T; Tam-Amersdorfer, C; Brunner, PM; Stary, G; Bakiri, L; Wagner, EF; Strobl, H; Sibilia, M Psoriatic skin inflammation is promoted by c-Jun/AP-1-dependent CCL2 and IL-23 expression in dendritic cells.
EMBO Mol Med. 2021; e12409-e12409 Doi: 10.15252/emmm.202012409 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Prochazka, KT; Neumeister, P Chronic lymphocytic leukaemia-what is new and notable in 2021, with a special focus on COVID-19.
Memo. 2021; 1-4 Doi: 10.1007/s12254-021-00735-z [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Riedl, JM; Hasenleithner, SO; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stöger, H; Berghold, A; Hoefler, G; Speicher, MR; Heitzer, E; Gerger, A Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
Ther Adv Med Oncol. 2021; 13:1758835920987658 Doi: 10.1177/1758835920987658 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Rosenkranz, AR; Tesar, V Lupus nephritis and ANCA-associated vasculitis: towards precision medicine?
Nephrol Dial Transplant. 2021; 36(Supplement_2): 37-43. Doi: 10.1093/ndt/gfab166 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Scheipl, S; Barnard, M; Lohberger, B; Zettl, R; Brcic, I; Liegl-Atzwanger, B; Rinner, B; Meindl, C; Fröhlich, E Drug combination screening as a translational approach toward an improved drug therapy for chordoma.
Cell Oncol (Dordr). 2021; 44(6):1231-1242 Doi: 10.1007/s13402-021-00632-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stoeger, H; Leithner, A; Heitzer, E; Liegl-Atzwanger, B; Szkandera, J Molecular profiling of soft-tissue sarcomas with FoundationOne® Heme identifies potential targets for sarcoma therapy: a single-centre experience.
Ther Adv Med Oncol. 2021; 13:17588359211029125 Doi: 10.1177/17588359211029125 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Šutić, M; Vukić, A; Baranašić, J; Försti, A; Džubur, F; Samaržija, M; Jakopović, M; Brčić, L; Knežević, J Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management.
J Pers Med. 2021; 11(11): Doi: 10.3390/jpm11111102 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2020

de, Groot, K; Aries, PM; Haubitz, M; Hellmich, B; Lamprecht, P; Thiel, J [Anti B-cell-antibody treatment for maintenance of remission in granulomatosis with polyangiitis and microscopic polyangiitis].
DEUT MED WOCHENSCHR. 2020; 145(1): 40-46. Doi: 10.1055/a-1060-2736
Web of Science PubMed FullText FullText_MUG

 

Duan, Y; Haybaeck, J; Yang, Z Therapeutic Potential of PI3K/AKT/mTOR Pathway in Gastrointestinal Stromal Tumors: Rationale and Progress.
Cancers (Basel). 2020; 12(10): Doi: 10.3390/cancers12102972 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Gatterbauer, B; Hirschmann, D; Eberherr, N; Untersteiner, H; Cho, A; Shaltout, A; Göbl, P; Fitschek, F; Dorfer, C; Wolfsberger, S; Kasprian, G; Höller, C; Frischer, JM Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy-A retrospective cohort study.
Cancer Med. 2020; 9(11):4026-4036 Doi: 10.1002/cam4.3021 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Haferkamp, S; Alter, M; Debus, D; Schilling, B; Pinter, A; Terheyden, P; Utikal, JS; Sachse, MM; Haalck, T; Wolf, IH Patients with BRAF-Mutant Advanced/Metastatic Melanoma: Original Research on the Treatment Reality in Germany and Austria in the Era of Choice.
Adv Ther. 2020; 37(8): 3619-3629. Doi: 10.1007/s12325-020-01430-x
Web of Science PubMed FullText FullText_MUG

 

Hamrick, SEG; Sallmon, H; Rose, AT; Porras, D; Shelton, EL; Reese, J; Hansmann, G Patent Ductus Arteriosus of the Preterm Infant.
Pediatrics. 2020; 146(5): Doi: 10.1542/peds.2020-1209 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hansmann, G; Apitz, C; Humpl, T; Koestenberger, M; Michel-Behnke, I; Schulze-Neick, I; Quandt, D; Lammers, AE Urgent need for off-label use of PAH medications and reimbursement for children with pulmonary hypertension Statement of the Working Group on Pulmonary Hypertension of the German Society for Pediatric Cardiology and Congenital Cardiac Defects (DGPK).
MONATSSCHR KINDERH. 2020; Doi: 10.1007/s00112-020-00924-w [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Kaemmerer, H; Gorenflo, M; Huscher, D; Pittrow, D; Apitz, C; Baumgartner, H; Berger, F; Bruch, L; Brunnemer, E; Budts, W; Claussen, M; Coghlan, G; Dähnert, I; D'Alto, M; Delcroix, M; Distler, O; Dittrich, S; Dumitrescu, D; Ewert, R; Faehling, M; Germund, I; Ghofrani, HA; Grohé, C; Grossekreymborg, K; Halank, M; Hansmann, G; Harzheim, D; Nemes, A; Havasi, K; Held, M; Hoeper, MM; Hofbeck, M; Hohenfrost-Schmidt, W; Jurevičienė, E; Gumbienè, L; Kabitz, HJ; Klose, H; Köhler, T; Konstantinides, S; Köestenberger, M; Kozlik-Feldmann, R; Kramer, HH; Kropf-Sanchen, C; Lammers, A; Lange, T; Meyn, P; Miera, O; Milger-Kneidinger, K; Neidenbach, R; Neurohr, C; Opitz, C; Perings, C; Remppis, BA; Riemekasten, G; Scelsi, L; Scholtz, W; Simkova, I; Skowasch, D; Skride, A; Stähler, G; Stiller, B; Tsangaris, I; Vizza, CD; Vonk Noordegraaf, A; Wilkens, H; Wirtz, H; Diller, GP; Grünig, E; Rosenkranz, S Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry.
J Clin Med. 2020; 9(5): Doi: 10.3390/jcm9051456 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Opatz, S; Bamopoulos, SA; Metzeler, KH; Herold, T; Ksienzyk, B; Bräundl, K; Tschuri, S; Vosberg, S; Konstandin, NP; Wang, C; Hartmann, L; Graf, A; Krebs, S; Blum, H; Schneider, S; Thiede, C; Middeke, JM; Stölzel, F; Röllig, C; Schetelig, J; Ehninger, G; Krämer, A; Braess, J; Görlich, D; Sauerland, MC; Berdel, WE; Wörmann, BJ; Hiddemann, W; Spiekermann, K; Bohlander, SK; Greif, PA The clinical mutatome of core binding factor leukemia.
Leukemia. 2020; 34(6): 1553-1562. Doi: 10.1038/s41375-019-0697-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Richtig, E The therapeutic landscape of advanced melanoma.
MEMO-MAG EUR MED ONC. 2020; Doi: 10.1007/s12254-020-00593-1 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Roessner, A; Smolle, M; Haybäck, J [Giant cell tumor of bone : Morphology, molecular pathogenesis, and differential diagnosis].
Pathologe. 2020; 41(2):134-142 Doi: 10.1007/s00292-020-00760-5
Web of Science PubMed FullText FullText_MUG

 

Seidel, MG Treatment of immune-mediated cytopenias in patients with primary immunodeficiencies and immune regulatory disorders (PIRDs).
Hematology Am Soc Hematol Educ Program. 2020; 2020(1): 673-679. Doi: 10.1182/hematology.2020000153 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Skálová, A; Banečkova, M; Thompson, LDR; Ptáková, N; Stevens, TM; Brcic, L; Hyrcza, M; Michal, M; Simpson, RHW; Santana, T; Michal, M; Vaněček, T; Leivo, I Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion.
Am J Surg Pathol. 2020; 44(10):1295-1307 Doi: 10.1097/PAS.0000000000001535
Web of Science PubMed FullText FullText_MUG

 

Studnicka, M; Baumgartner, B; Bolitschek, J; Doberer, D; Eber, E; Eckmayr, J; Hartl, S; Hesse, P; Jaksch, P; Kink, E; Kneussl, M; Lamprecht, B; Olschewski, H; Pfleger, A; Pohl, W; Prior, C; Puelacher, C; Renner, A; Steflitsch, W; Stelzmüller, I; Täubl, H; Vonbank, K; Wagner, M; Wantke, F; Wass, R [Masterplan 2025 of the Austrian Society of Pneumology (ASP)-the expected burden and management of respiratory diseases in Austria].
Wien Klin Wochenschr. 2020; 132(Suppl 3): 89-113. Doi: 10.1007/s00508-020-01722-w [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Bakhtiar, S; Fekadu, J; Seidel, MG; Gambinieri, E Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Immune Dysregulatory Disorders.
Front Pediatr. 2019; 7: 461-461. Doi: 10.3389/fped.2019.00461 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Balic, M; Thomssen, C; Würstlein, R; Gnant, M; Harbeck, N St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment.
Breast Care (Basel). 2019; 14(2):103-110 Doi: 10.1159/000499931 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum